Total planned funding: $115,785,040
Allocations
Countries/Regions
Ukraine | $115,785,040 |
Organizational Types
Unknown | $31,518,021 |
Private Contractor | $28,990,981 |
NGO | $19,969,354 |
Own Agency | $13,142,383 |
Multi-lateral Agency | $10,775,607 |
University | $5,277,000 |
Other USG Agency | $3,061,694 |
Implementing Agency | $2,800,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $49,656,751 |
Treatment | $24,203,765 |
Prevention | $12,293,355 |
Testing | $11,402,467 |
Care | $9,164,272 |
Management and Operations | $8,651,730 |
Budget Codes
OHSS: Health Systems Strengthening | $24,438,893 |
HVSI: Strategic Information | $15,509,847 |
HTXS: Treatment: Adult Treatment | $12,772,651 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HVCT: Testing: HIV Testing and Counseling | $11,402,467 |
HLAB: Laboratory Infrastructure | $9,708,011 |
HVMS: Management and Operations | $8,651,730 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,511,890 |
HVTB: Care: TB/HIV | $5,498,728 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,907,557 |
HKID: Care: Orphans and Vulnerable Children | $1,844,509 |
HBHC: Care: Adult Care and Support | $1,821,035 |
HMBL: Biomedical Prevention: Blood Safety | $1,133,557 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $196,994 |
Top Partner Programs
Not Available:
$32,222,737
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$12,608,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions